← FDA DRUG APPROVALS

FDA ANDA · ANDA087655

SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE

Sponsor: VANGARD

APPLICATION
ANDA087655
TYPE
ANDA
ORIGINAL APPROVAL
1981-12-14
LATEST ACTION
1987-10-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDEDiscontinued
HYDROCHLOROTHIAZIDE 25MG, SPIRONOLACTONE 25MG · TABLET · ORAL

Approval history

1987-10-07Manufacturing (CMC) · Supplement 5AP
1981-12-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →